Abstract
Background
Capsaicin is the main compound found in chili pepper and has complex pharmacologic effects. This study aimed to elucidate the mechanism of the effect of capsaicin on physiological processes by analyzing changes in metabolites and metabolic pathways.
Methods
Female C57BL/6 mice were divided into two groups(n = 10/group) and fed with capsaicin-soybean oil solution(group T) or soybean oil(group C) for 6 weeks. Ultra-high performance liquid chromatography/quadrupole time-of-flight mass spectrometry (UHPLC-qTOF-MS) based metabolomics was undertaken to assess plasma and skin metabolic profile changes and identify differential metabolites through multivariate analysis.
Results
According to the OPLS-DA score plots, the plasma and skin metabolic profiles in the group T and group C were significantly separated. In plasma, 38 significant differential metabolites were identified. KEGG pathway enrichment analysis revealed that the most significant plasma metabolic pathways included pyruvate metabolism and ABC transporters. In skin, seven significant differential metabolites were found. Four metabolic pathways with p values < 0.05 were detected, including sphingolipid metabolism, sphingolipid signaling pathway, apoptosis, and necroptosis.
Conclusion
These findings will provide metabolomic insights to assess the physiological functions of capsaicin and contribute to a better understanding of the potential effects of a capsaicin-rich diet on health.
Abbreviations
UHPLC/Q-TOF MS, Ultra-high-performance liquid chromatography and Q-TOF mass spectrometry; NH4AC, Ammonium acetate; NH4OH, Ammonium hydroxide; QC, Quality control; PCA, Pareto-scaled principal component analysis; OPLS-DA, Orthogonal partial least-squares discriminant analysis; VIP, Variable importance in the projection; KEGG, Kyoto encyclopedia of genes and genomes; ROC, Receiver operating characteristic; FC, Fold Change.
Institutional Review Board Statement
All animal experiments were performed according to the regulation of institutional guidelines for the care and use of experimental animals and approved by the Animal Ethical Committee of The Second Affiliated Hospital of Nanchang University.
Data Sharing Statement
The datasets during and/or analysed during the current study available from the corresponding author on reasonable request.
Acknowledgments
We thank Dr. Xiuping Wang and Dr. Xiaoliang OU-Yang for their assistance in data analysis and verification.
Author Contributions
All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.
Disclosure
The authors declare no conflicts of interest in this work.